Overview

Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This is a Phase 4, single center, open label, fixed-sequence, multiple dose, 2-way drug-drug interaction study.
Phase:
Phase 4
Details
Lead Sponsor:
Kowa Research Institute, Inc.
Treatments:
Darunavir
Pitavastatin
Ritonavir